Shanthi Ganesh

Company: Dicerna Pharmaceuticals

Job title: Director, Discovery Research Pre-Clinical Oncology

Seminars:

Overcoming Tumor Resistance by Leveraging RNAi 2:30 pm

• Role of tumor associated immune cells in creating a suppressive tumor microenvironment (TME) • Strategies to overcome tumor resistance in the context of the TME • Understanding how RNAi could play a key role in converting an immunotherapy resistant phenotype to inflamed tumor phenotype • RNAi mediated activity in immunotherapy resistant sensitive tumorsRead more

day: Day One Track B PM